Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States

Chow, 2010, Epidemiology and risk factors for kidney cancer, Nat Rev Urol, 7, 245, 10.1038/nrurol.2010.46

Nguyen, 2017, Advances in the diagnosis of hereditary kidney cancer: initial results of a multigene panel test, Cancer, 123, 4363, 10.1002/cncr.30893

Inamura, 2017, Renal cell tumors: understanding their molecular pathological epidemiology and the 2016 WHO classification, Int J Mol Sci, 18, 2195, 10.3390/ijms18102195

Humphrey, 2016, The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours, Eur Urol, 70, 106, 10.1016/j.eururo.2016.02.028

Cairns, 2010, Renal cell carcinoma, Cancer Biomark, 9, 461, 10.3233/CBM-2011-0176

Owens, 2016, Kidney cancer, Nature, 537, S97, 10.1038/537S97a

Aleksander, 1995

Patel, 2007, Applications of artificial neural networks in medical science, Curr Clin Pharmacol, 2, 217, 10.2174/157488407781668811

Jäger, 2014, Desert hedgehog (DHH) is an independent prognosticator of oncologic outcome in clear cell renal cell carcinoma, J Urol, 192, 1842

Yu, 2018, miRNA-21 and miRNA-223 expression signature as a predictor for lymph node metastasis, distant metastasis and survival in kidney renal clear cell carcinoma, J Cancer, 9, 3651

White, 2014, Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma, Oncotarget, 5, 506, 10.18632/oncotarget.1529

Rogers, 2003, Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis identification of key issues affecting potential clinical utility, Cancer Res, 63, 6971

Zira, 2010, 1H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool, J Proteome Res, 9, 4038, 10.1021/pr100226m

Gao, 2008, Metabonomic profiling of renal cell carcinoma: high resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis, Anal Chim Acta, 624, 269, 10.1016/j.aca.2008.06.051

Zheng, 2016, Prediction and diagnosis of renal cell carcinoma using nuclear magnetic resonance–based serum metabolomics and self-organizing maps, Oncotarget, 7, 59189, 10.18632/oncotarget.10830

Wang, 2008, Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic, Obesity (Silver Spring), 16, 2323, 10.1038/oby.2008.351

Ng, 2014, Smoking prevalence and cigarette consumption in 187 countries, 1980-2012, JAMA, 311, 183, 10.1001/jama.2013.284692

Yoon

Saad, 2019, Trends in renal-cell carcinoma incidence and mortality in the United States in the last 2 decades: a SEER-based study, Clin Genitourin Cancer, 17, 46, 10.1016/j.clgc.2018.10.002

Bongaarts, 2006, How long will we live?, Popul Dev Rev, 32, 605, 10.1111/j.1728-4457.2006.00144.x

Wilmoth, 2000, Demography of longevity: past, present, and future trends, Exp Gerontol, 35, 1111, 10.1016/S0531-5565(00)00194-7

Kochanek, 2017, Mortality in the United States, 2016, NCHS Data Brief, 293, 1

Sanchez-Ortiz, 2004, Young age is an independent prognostic factor for survival of sporadic renal cell carcinoma, J Urol, 171, 2160

Taccoen, 2007, Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival, Eur Urol, 51, 980, 10.1016/j.eururo.2006.10.025

Verhoest, 2007, Relationship between age at diagnosis and clinico-pathologic features of renal cell carcinoma, Eur Urol, 51, 1298, 10.1016/j.eururo.2006.11.056

Lopez-Beltran, 2006, 2004 WHO classification of the renal tumors of the adults, Eur Urol, 49, 798, 10.1016/j.eururo.2005.11.035

Porta, 2012, How to identify active novel agents in rare cancers and then make them available: a need for a paradigm shift, Eur Urol, 62, 1020, 10.1016/j.eururo.2012.07.035